| Safety and Immunogenicity of PRO-169 in Patients With Diabetic Macular Edema (NCT07429474) | Laboratorios Sophia S.A de C.V. | 2026-03-01 |
| Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface. (NCT06379685) | Laboratorios Sophia S.A de C.V. | 2025-12-30 |
| PRO-232 in Patients Subjected to Cataract Surgery (NCT07305987) | Laboratorios Sophia S.A de C.V. | 2025-10-27 |
| Evaluation of Manzanilla® and Meticel Ofteno® 0.5% for Providing a Relief Sensation to the Eyes (NCT06859476) | Laboratorios Sophia S.A de C.V. | 2025-05-23 |
| Study of Non-inferiority Between Manzanilla Sophia® and Meticel Ofteno® 0.5% for Providing a Soothing Sensation to the Eyes. (NCT06373653) | Laboratorios Sophia S.A de C.V. | 2025-02-11 |
| Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF (NCT06370585) | Laboratorios Sophia S.A de C.V. | 2024-05-16 |
| Study Evaluating PRO-232 an Ophthalmic Solution Compared to Placebo. (NCT06352541) | Laboratorios Sophia S.A de C.V. | 2024-02-08 |
| Study to Evaluate the Safety and Tolerability of PRO-231 Versus VIGAMOXI® on the Ocular Surface of Healthy Subjects (NCT06363292) | Laboratorios Sophia S.A de C.V. | 2024-01-30 |
| Safety and Tolerability of PRO-185 (NCT05470868) | Laboratorios Sophia S.A de C.V. | 2023-02-04 |
| Safety and Tolerability Evaluation of PRO-230 Ophthalmic Solution (NCT05481489) | Laboratorios Sophia S.A de C.V. | 2023-02-01 |
| Study to Evaluate the Efficacy of Lagricel® Ofteno PF Compared to Thealoz® Duo After Photorefractive Keratectomy (NCT04704518) | Laboratorios Sophia S.A de C.V. | 2022-09-03 |
| Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201 (NCT05470881) | Laboratorios Sophia S.A de C.V. | 2022-08-20 |
| Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease. (NCT04704531) | Laboratorios Sophia S.A de C.V. | 2022-01-03 |
| Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye. (NCT04702776) | Laboratorios Sophia S.A de C.V. | 2021-12-09 |
| Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension. (NCT04702789) | Laboratorios Sophia S.A de C.V. | 2021-10-19 |
| Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema (NCT05217680) | Laboratorios Sophia S.A de C.V. | 2021-05-24 |
| Clinical Trial to Compare the Safety and Efficacy of Nanodrop® (NCT04111965) | Laboratorios Sophia S.A de C.V. | 2020-12-01 |
| Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+ (NCT04693429) | Laboratorios Sophia S.A de C.V. | 2020-09-24 |
| Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution (NCT04081610) | Laboratorios Sophia S.A de C.V. | 2019-09-09 |
| Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno® (NCT03966365) | Laboratorios Sophia S.A de C.V. | 2019-05-02 |
| Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan® (NCT03965052) | Laboratorios Sophia S.A de C.V. | 2019-04-24 |
| Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification (NCT03693989) | Laboratorios Sophia S.A de C.V. | 2018-10-04 |
| Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. (NCT03696342) | Laboratorios Sophia S.A de C.V. | 2018-10-01 |
| Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel (NCT03697876) | Laboratorios Sophia S.A de C.V. | 2018-08-20 |
| Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects (NCT03519516) | Laboratorios Sophia S.A de C.V. | 2018-01-25 |
| Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo. (NCT03521791) | Laboratorios Sophia S.A de C.V. | 2017-12-13 |
| PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM) (NCT03193333) | Laboratorios Sophia S.A de C.V. | 2017-11-06 |
| Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects. (NCT03520348) | Laboratorios Sophia S.A de C.V. | 2017-10-04 |